Literature DB >> 325238

Codeine and propoxyphene in postepisiotomy pain. A two-dose evaluation.

C M Gruber.   

Abstract

In a double-blind control study, oral doses of placebo, propoxyphene napsylate (50 or 100 mg), or codeine sulfate (30 or 60 mg) were administered to 46 postepisiotomy patients, grouped by severity of pain reported at first-dose drug administration. Eight hourly observations by a trained observer provided estimates of analgesia. The analgesia scores for placebo treatments were significantly lower than for the lesser doses of either drug (P less than .05) as well as for the greater doses (P less than .01). At both dose levels, the analgesia scores for both drugs were almost identical. Analgesia with the higher doses was greater than with the lower, but not to a statistically significant extent. The difference in patient responses increased following the second dose. No serious adverse reactions occurred; the elicited and volunteered reports of minor side effects were similar for all five treatments.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325238

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration.

Authors:  H Quiding; P Anderson; U Bondesson; L O Boréus; P A Hynning
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 3.  Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period.

Authors:  Edgardo Abalos; Yanina Sguassero; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2021-01-08

4.  How women view postepisiotomy pain.

Authors:  A E Reading; C M Sledmere; D N Cox; S Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.